Literature DB >> 11874488

Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid.

Katsushi Yamamoto1, Naokazu Inoue, Riako Masuda, Akira Fujimori, Toshiyuki Saito, Shinobu Imajoh-Ohmi, Hiroshi Shinkai, Hisako Sakiyama.   

Abstract

Bullous pemphigoid is an inflammatory subepidermal blistering skin disease associated with an IgG autoimmune response to the type XVII collagen. The immunopathologic features of bullous pemphigoid can be reproduced in mice by the passive transfer of anti-type XVII collagen antibodies. In this model, it is thought that blister formation depends upon complement activation, neutrophil recruitment, and some proteolytic enzymes. In this study, we cloned hamster type XVII collagen cDNA, which contains a 4296 bp coding region and which is predicted to be a transmembrane protein with an extracellular collagenous domain, residing in type II orientation. Antipeptide antibodies (anti-1191 IgG) were obtained against a segment of hamster type XVII collagen homologous with the human type XVII collagen autoantibody-reactive site. The antipeptide antibodies were passively transferred to neonatal Syrian hamsters. The injected hamsters developed a microscopic subepidermal blister as seen previously in the mice. In order to test whether antigen-antibody complexes and complement initiate the subepidermal blister formation, we carried out experiments in vitro on condition that inflammatory cells were completely eliminated. Complement activation in sera was inhibited either by heating (at 56 degrees C for 30 min) or by preincubating with cobra venom factor. When the hamster skin was incubated with fresh anti-1191 antisera, separation of dermal-epidermal junction was observed. The anti-1191 IgG failed to induce C3 deposition and dermal-epidermal junction separation, however, if the anti-1191 IgG was added alone or complement activation in sera was inhibited. Under these conditions, IgG but not C3 was deposited on the basement membrane. These results strongly suggest that antigen-antibody complexes and complement initiate dermal-epidermal junction separation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11874488     DOI: 10.1046/j.0022-202x.2001.01683.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  16 in total

Review 1.  What's new in blistering disorders?

Authors:  Paru Chaudhari; M Peter Marinkovich
Journal:  Curr Allergy Asthma Rep       Date:  2007-07       Impact factor: 4.806

Review 2.  A Review of the Immunologic Pathways Involved in Bullous Pemphigoid and Novel Therapeutic Targets.

Authors:  Mohsen Afarideh; Robert Borucki; Victoria P Werth
Journal:  J Clin Med       Date:  2022-05-18       Impact factor: 4.964

Review 3.  The pathophysiology of bullous pemphigoid.

Authors:  Michael Kasperkiewicz; Detlef Zillikens
Journal:  Clin Rev Allergy Immunol       Date:  2007-10       Impact factor: 8.667

4.  Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases.

Authors:  Kinga Csorba; Sabine Schmidt; Florina Florea; Norito Ishii; Takashi Hashimoto; Michael Hertl; Sarolta Kárpáti; Leena Bruckner-Tuderman; Wataru Nishie; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2011-05-28       Impact factor: 4.123

5.  The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice.

Authors:  Eva Oswald; Alina Sesarman; Claus-Werner Franzke; Ute Wölfle; Leena Bruckner-Tuderman; Thilo Jakob; Stefan F Martin; Cassian Sitaru
Journal:  PLoS One       Date:  2012-02-06       Impact factor: 3.240

Review 6.  The relevance of the IgG subclass of autoantibodies for blister induction in autoimmune bullous skin diseases.

Authors:  Cassian Sitaru; Sidonia Mihai; Detlef Zillikens
Journal:  Arch Dermatol Res       Date:  2007-02-03       Impact factor: 3.017

7.  Pathogenicity of autoantibodies in anti-p200 pemphigoid.

Authors:  Katerina Vafia; Stephanie Groth; Tina Beckmann; Misa Hirose; Jenny Dworschak; Andreas Recke; Ralf J Ludwig; Takashi Hashimoto; Detlef Zillikens; Enno Schmidt
Journal:  PLoS One       Date:  2012-07-24       Impact factor: 3.240

8.  Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice.

Authors:  Mircea Teodor Chiriac; Emilia Licarete; Alexandra Gabriela Sas; Andreea Maria Rados; Iulia Lupan; Anca Mirela Chiriac; Hilda Speth; Vlad Pop-Vancia; Iacob Domsa; Alina Sesarman; Octavian Popescu; Cassian Sitaru
Journal:  Orphanet J Rare Dis       Date:  2013-01-29       Impact factor: 4.123

Review 9.  Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid.

Authors:  Lisa Leighty; Ning Li; Luis A Diaz; Zhi Liu
Journal:  Arch Dermatol Res       Date:  2007-09-19       Impact factor: 3.017

Review 10.  Immunopathology and molecular diagnosis of autoimmune bullous diseases.

Authors:  Sidonia Mihai; Cassian Sitaru
Journal:  J Cell Mol Med       Date:  2007 May-Jun       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.